Current Research into Cures for Type-1 Diabetes

In the US, we are in the "Walking Season" when JDRF (Juvenile Diabetes Research Foundation) asks us to walk to raise money for a ...

Iscalimab, also known by its "code name" of CFZ533 started a phase-II? trial last November, and is expected to finish in October 2...

Here are three recent updates on Teplizumab.  You can read my previous summary of this drug here: https://cureresearch4type1diabetes.blogspo...

Hydroxychloroquine to Prevent Type 1 Diabetes Hydroxychloroquine (HCQ) has been in the news recently because of claims that it may treat/cur...

June 12th to 16th was ADA 2020, the scientific sessions of the American Diabetes Association, which is the largest diabetes focused medical ...

This blog posting is a summary of four small updates.  Unfortunately, they include research delay, two unsuccessful trials, and one trial un...

This blog is different from most of my blogs because I'm reporting on a case study rather than a clinical trial.  A case study is the ex...